DeepTech Investor Summit

UNOMR AG

ETH spin-off

unomr.comZurich, Switzerland
11 profile visits

About

UNOMR, a techBio startup from ETH Zurich, is pioneering single-molecule protein sequencing through their innovative interface nanopore sensor, currently with a focus on site-specific protein glycosylation. Adressing a US$ 60B market, their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering a powerful new tool for therapeutic discovery and medical food product innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.

Social media

Covered funding stages of your organization / Spin-off Funding Stage

Pre-SeedSeed

Industry Sector your organization invests in / Industry Sector of your Spin-off

Bio Tech

Target Markets of your organization / Expansion or target markets of your spin-off

Global

Representatives

CEO & co-founder UNOMR AG

UNOMR AG

COO at UNOMR

UNOMR AG

CTO & Co-Founder

UNOMR AG